TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Complexa raises $13M to fund trials of kidney disease drug

Wednesday, June 4, 2014, 10:51 a.m.
 

Complexa Inc., a South Side-based drug development company, said it raised $13 million from investors that will fund clinical trials of a drug to treat kidney disease.

The funding round, Complexa's second, was led by Jafco Life Science Investment, an arm of Japanese private equity firm Jafco Co. Ltd.

The company previously raised more than $8 million from venture capital investors to license and develop molecules discovered and patented by professor Bruce Freeman and a team of researchers at the University of Pittsburgh.

There is “great interest” in Complexa's work from large pharmaceutical companies, Jafco officials said in a statement.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Visual search  still hampered  by image issues
  2. Deported migrants find home at call centers
  3. U-PARC houses companies ranging from innovative to traditional
  4. Young adults drive home rental trend in Western Pennsylvania
  5. 2 top technology officers leave UPMC
  6. Students walk shop class path to excellence
  7. DQE Communication inks data deal with Iron Mountain
  8. States clear way for startups to use crowdfunding
  9. Lower your cable bill by streaming shows
  10. States fight back against financial scams aimed at seniors
  11. Microsoft keeping $93B offshore, off U.S. tax rolls
Subscribe today! Click here for our subscription offers.